rebel Financial rebel Financial
← All Posts
BCRX

BIOCRYST PHARMACEUTICALS, INC.

June 12, 2026 • Author: Phil Ratcliff • BCRX
Item Proposal Vote
1 ELECTION OF DIRECTORS
1a Theresa M. Heggie ✓ For
1b Amy E. McKee, M.D. ✓ For
1c Jon P. Stonehouse ✗ Against
2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR 2026 ✓ For
3 NON-BINDING, ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION ✓ For
4 APPROVAL OF AN AMENDED AND RESTATED STOCK INCENTIVE PLAN, INCREASING THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE STOCK INCENTIVE PLAN ✓ For
Attachments
📄
BCRX_ANNUAL_REPORT_2025.pdf 1.3 MB
📄
BCRX_PROXY_STATEMENT.pdf 1.0 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.